CN104306385A - Tympanitis dropping liquid - Google Patents
Tympanitis dropping liquid Download PDFInfo
- Publication number
- CN104306385A CN104306385A CN201410461453.4A CN201410461453A CN104306385A CN 104306385 A CN104306385 A CN 104306385A CN 201410461453 A CN201410461453 A CN 201410461453A CN 104306385 A CN104306385 A CN 104306385A
- Authority
- CN
- China
- Prior art keywords
- tympanitis
- patients
- disease
- cure
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The name of the invention is tympanitis dropping liquid which is a topical product, the product is mainly used for the treatment of adults and children patients with tympanitis, the tympanitis dropping liquid is the topical product for easy cure of the tympanitis disease before the tympanitis disease develops to operation. In the prior art, the tympanitis is treated by two methods in medical field, the two methods comprise a drug treatment method and a tympanoplasty treatment method, the drug treatment method uses internally-applied antibiotic, and has the following shortages: the patients are slow to cure, the course of disease is long, the pain brought to the patients long, and some patients cannot be cured for a plurality years or even decades; the aim of the invention is to provide the patients the topical product for easily curing the tympanitis, the shortages that in the prior art, the drug therapy course of the tympanitis is long, the tympanitis is difficult to cure, operation treatment cost is high, and the tympanitis has the risk of recurrence can be overcome, and economic and ideological pressure of the patients can be fundamentally reduced.
Description
Technical field
This technology is applied in medical domain, to the patient obtaining otitis media, and a kind of externally applied product of light healing.
Background technology
About otitis media, in this background technology field, present people are to otitis media patient, the method adopted, generally have two kinds, one is operation method for the treatment of, and one is medicine method for the treatment of, operation method for the treatment of generally adopts " Tympanoplasty operative therapy ", and the general doctor of medicine method for the treatment of is many, and employing uses antibiotic in patient.
Summary of the invention
A. title of the present invention is otitis media dropping liquid, is a kind of externally applied product, and product mainly obtains the treatment of the patient of otitis media disease to adult or child, is that one does not allow this disease develop into stage of performing an operation as far as possible, the externally applied product of easily curing.B. the present invention relates at medical domain, to the patient obtaining otitis media, a kind of externally applied product of light healing.C. prior art and background technology.Present medical circle is to the method for the treatment of of this disease, and medicine method for the treatment of, uses antibiotic method in adopting, and not enough place is: what allow patient cure is slow, and the course of disease is long, and the misery brought to patient is long, and some patients several years, even more than ten years can not cure.Another method is the method with operative treatment, " Dong Min sound clinical experience collects " chapter 5 auditory rehabilitation art tympanoplasty that publishing house of Zhengzhou University 2002-1-1 publishes---interplantation Split flap tympanum patching tent support formula Middle otoplasty summary under tympanic ring, teach the method that tympanoplasty treats this disease, the operation plan of the hospital also had also is adopt tympanoplasty more, this method efficiently can be treated middle ear focus and be rebuild the hands art of tympanum acoustic structure, object removes focus, and repair tympanum and rebuild ossicular chain, to reach the object improved one's hearing.But the misery that operation brings to patient is large, except surgery cost height, the hot a heatable brick bed if patient sleeps again, but patient's disease relapse can not be got rid of, carry out surgical risks next time possibly.If patient early finds, early treatment, allows the disease of patient not develop into the stage that have to perform the operation, and fundamentally alleviates economy and the thought pressure of patient.D. the present invention seeks to overcome this disease in the prior art, the course of disease that pharmacotherapy brings to patient is long, is difficult to cure, and expenses of surgical treatment is high, and also have the deficiency of risk of relapse, and provide a kind of product allowing the external of the early stage healing otitis media easily of patient cure to patient.The technical scheme of e. inventing.The present invention is reached by following measure, and pharmaceutical formulation is the ratio compatibility with 800,000 units of Penicillin and each one of streptomycin sulfate 4ml:0.2g dosage form.Using method is, the ejection in patient's ear is cleaned out, then to be gone directly affected part by topical administration, stock solution good for absorbent cotton compatibility on cotton-ball bar is dripped wet at every turn, put into ear affected part gently, and wall, return multiple three, four times like this, once a day, can entirely heal within general one week.F. the advantage that the present invention compared with prior art has is instant effect, and expense is low, simple to operate, cuts recurrent little, does not dally over one's work and learns.The tired brain allowing patient easily remove otitis media to bring, also may not well develop into the stage of performing an operation.H. embodiment or concrete embodiment.Can adopt the patient that the course of disease is different, the patient of the different course of disease of such as heavy, medium and light, adopts said method treatment, pay a return visit after a time, but hot a heatable brick bed and other reason of originally having an attack of one's old illness is not offended again it is specifically intended that patient does not sleep again.
Claims (2)
1. pair prescription Chinese medicine kind and metering protection.
2. pair this pharmaceutical formulation protects with the ratio compatibility of 800,000 units of Penicillin and each one of streptomycin sulfate 4ml:0.2g dosage form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410461453.4A CN104306385A (en) | 2014-09-12 | 2014-09-12 | Tympanitis dropping liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410461453.4A CN104306385A (en) | 2014-09-12 | 2014-09-12 | Tympanitis dropping liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104306385A true CN104306385A (en) | 2015-01-28 |
Family
ID=52361796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410461453.4A Pending CN104306385A (en) | 2014-09-12 | 2014-09-12 | Tympanitis dropping liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104306385A (en) |
-
2014
- 2014-09-12 CN CN201410461453.4A patent/CN104306385A/en active Pending
Non-Patent Citations (4)
Title |
---|
云裕: "化脓性中耳炎的有效疗法", 《中级医刊》 * |
李文汉: "《新编儿科药物手册》", 31 December 1999 * |
李源: "耳局部应用抗生素的耳毒性", 《国外医学 耳鼻咽喉科学分册》 * |
许士凯: "《新编药物手册》", 31 August 2003 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021007592A (en) | Macrocyclic compounds and their use in the treatment of disease. | |
EA201300558A1 (en) | CONNECTIONS AND METHODS FOR MORNING PAIN | |
SG10201903578VA (en) | Indole carboxamides compounds useful as kinase inhibitors | |
EA201200686A1 (en) | NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
EA200802204A1 (en) | APPLICATION OF DPP IV INHIBITORS | |
EA202090043A1 (en) | Diazabicyclic substituted imidazopyrimidines and their use | |
EA201491460A1 (en) | APPLICATION OF LACHINIMODA IN THE TREATMENT OF PATIENTS WITH CRONE'S DISEASE, WHICH ARE NOT EFFECTIVE THERAPY OF THE FIRST LINE ANTI-TNFα | |
MX356343B (en) | Compounds which inhibit neuronal exocytosis (ii). | |
MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
HRP20161147T1 (en) | Pharmaceutical composition and manufacturing method therefor | |
BR112021026369A2 (en) | 2h-indazole derivatives and their use in the treatment of diseases | |
WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
Makedonova et al. | Studying clinical and pathomorphological changes in gingival tissues when applying platelet-rich autoplasma regenerative method | |
UA109359C2 (en) | TREATMENT OF SKIN DISEASES AND STATES | |
CN104306385A (en) | Tympanitis dropping liquid | |
CA2863829A1 (en) | Oral unit dosage forms and uses of same for the treatment of gaucher disease | |
RU2011101076A (en) | METHOD OF REHABILITATION OF PATIENTS WITH CHILDREN'S CEREBRAL PARALYSIS | |
CN104645177A (en) | Traditional Chinese medicine composition for treating flat wart | |
CN105878405A (en) | Medicated bath formula for treating rheumatic bone pain | |
CN103550160A (en) | Anti-inflammatory drug powder | |
WO2014143763A3 (en) | Angiogenic compositions for wounds, articular joints and graft materials | |
CN105596467A (en) | Children cough treating traditional Chinese medicine formula | |
FR2960780B1 (en) | MEDICINE FOR THE TREATMENT OF PARKINSON'S DISEASE | |
RU2011121219A (en) | METHOD FOR TREATING INFLAMMATORY DISEASES OF THE PARADONT | |
Wang et al. | Nursing of patients with mandibular fractures treated with micro titanium plate rigid internal fixation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |